Author Question: According to the authors, what originally spurred the development of advertising for cigarettes and ... (Read 177 times)

Ebrown

  • Hero Member
  • *****
  • Posts: 567
According to the authors, what originally spurred the development of advertising for cigarettes and other products?
 
  a. the development of the ability to mass-produce products
  b. the development of new forms of media
  c. the growing desire of the public for information about the product
  d. the development of the entertainment industry

Question 2

How can cognitive dissonance create attitude change? Why isn't it used on mass scales in advertising?
 
  What will be an ideal response?



ntsoane kedibone

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

Answer: A

Answer to Question 2

Answer: When people advocate a point of view that goes against their attitude (counterattitudinal advocacy) and have little external justification for this action, they tend to experience dissonance, which motivates them to reduce it by changing their attitude to fall in line with their behaviors. It is not usually implemented on a large scale because it is difficult to find a way to make people engage in counterattitudinal advocacy and lack external justification.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

Hippocrates noted that blood separates into four differently colored liquids when removed from the body and examined: a pure red liquid mixed with white liquid material with a yellow-colored froth at the top and a black substance that settles underneath; he named these the four humors (for blood, phlegm, yellow bile, and black bile).

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

Everyone has one nostril that is larger than the other.

For a complete list of videos, visit our video library